Rutin is an inexpensive plant compound, found in foods like buckwheat and citrus, that the body slowly converts into related antioxidants. Its most consistent human benefit is easing symptoms of poor leg circulation and strengthening fragile small blood vessels — mostly shown with better-absorbed modified forms. Blood-sugar and inflammation signals are early; safety is strong and cost low. (Full Review)

Protocol

Standard Dose

250–500 mg

Once or twice daily (500–1,000 mg/day total)

Form

Rutin or rutoside derivative

Oxerutins/troxerutin better absorbed for venous symptoms

Timing

With meals

Twice daily with breakfast and dinner improves tolerability

Time to effect

Venous Symptoms

4–12 weeks

Before meaningful symptom relief is judged

Metabolic & Antioxidant Markers

4–12 weeks

Marker changes generally appear over this window

Single Dose

No immediate effect

No perceptible effect from a single dose

Benefits

Medium: Chronic venous insufficiency & varicose vein symptom relief; Capillary protection & reduced fragility

Low: Glycemic & metabolic support; Antioxidant & anti-inflammatory effects

Speculative: Antithrombotic effect; Neuroprotection & cognitive support; Anticancer potential; Longevity & healthspan extension

Contraindications

Active bleeding disorders

Full-dose anticoagulation

Within ~2 weeks of scheduled surgery

Pregnancy and breastfeeding

Key Interactions

Anticoagulant drugs (warfarin, apixaban, rivaroxaban, dabigatran, heparin)

Antiplatelet drugs (aspirin, clopidogrel, ticagrelor)

NSAIDs (ibuprofen, naproxen, aspirin)

Iron supplements and iron-rich meals

Blood-sugar-lowering drugs (metformin, sulfonylureas, berberine)

Additive antiplatelet/blood-thinning supplements (fish oil, vitamin E, ginkgo, garlic, curcumin, quercetin)

Quercetin and other flavonoids

Risk & Side Effects

Medium: Gastrointestinal disturbance

Low: Headache, flushing & rash; Increased bleeding tendency

Speculative: Reduced non-heme iron absorption; Pro-oxidant effects

Monitoring

Marker	Target	Why
hs-CRP	< 1.0 mg/L	Tracks systemic inflammation rutin may reduce
Fasting glucose	70–90 mg/dL	Gauges any glycemic effect when used for metabolic goals
HbA1c	< 5.4%	Reflects longer-term blood-sugar control
Complete blood count with platelets	Platelets ~150–400 ×10⁹/L	Baseline for bleeding-risk assessment when combined with blood thinners
INR	~2.0–3.0 if on warfarin; ~1.0 if not anticoagulated	Detects additive bleeding effect in warfarin users
ALT	< 25 U/L (men), < 20 U/L (women)	General safety marker; rutin is studied in fatty-liver contexts

Cadence: Baseline, reassess at ~3 months, then every 6–12 months; warfarin users check INR within 1–2 weeks of starting and after any dose change

Qualitative Assessment

Leg heaviness, aching, cramping, and swelling (venous goals)
Visible bruising or bleeding tendency (especially if combined with blood thinners)
Energy levels and general well-being
Skin appearance related to capillary fragility (spider veins, easy bruising)

Rutin for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment